Greenlab

15/06/2022

New Zealand-based biotechnology company Greenlab has joined forces with licenced producer Helius Therapeutics to develop specialised and targeted

14/06/2022

Thanks to our New Zealand farm media to pick the news on there own and of course on merit. "Leading researcher of medicinal cannabis Parmjit Randhawa of Greenlab says NZ can develop what it takes to sustainably grow h**p and be a leader in the global medicinal cannabis industry".
**p **pindustry

The global h**p industry is expected to grow to $65 billion by 2030 and with the right approach and regulatory system New Zealand could enjoy a large The global h**p industry is expected to grow to $65 billion by 2030 and with the right approach and regulatory system New Zealand could enjoy a large....

27/02/2022

“We have expanded again as we embark on the next stage of our journey.” Greenlab would like to welcome Dr Christine Stark as our Research Scientist.

Christine brings a depth of knowledge and experience to our R&D programme. Her passion for science, research expertise and practical know-how are build on a background in Commercial Horticultural (Hochschule Geisenheim University, Germany) and her PhD in Soil Microbiology from Lincoln University. Christine worked as a Postdoctoral Researcher at Teagasc (Ireland) and Manchester Metropolitan University (England, UK) and investigated agricultural management and environmental change interactions. Most recently, her research on Psa in kiwifruit at Lincoln University Bio-Protection Research Centre was instrumental to the development of the commercial biological control agent Kiwivax(TM).
With the synergy between Christine’s background and our leadership in medicinal cannabis research, it feels like we are cruising at speed in unexplored fascinating territory – bring it on!
Welcome aboard!

19/11/2021

Dr. Rupinder Brar & Dr. Parmjit Randhawa, co-founders of Greenlab join Sarah as this week's Change Maker to explain how the unique research could position New Zealand as the market leader in plant medicine as the pharmaceutical industry is running out of options for healthcare.

Whilst it won't be easy to capture a slice of the green pie on the ground, there are some excellent messages in the global trend for nutraceuticals.

02/09/2021

The gaps in medicinal cannabis disease resistance knowledge is a stumbling block to scale up production as risk of crop failure at large scale production facility may lead to colossal monetary losses. First few baby steps happening to record Powdery Mildew resistance gene.

12/08/2021

HEALTH HARVARD BLOG:
Dr Peter Grinspoon, MD

Our bodies produce molecules called endocannabinoids, which have a structural similarity to molecules in the cannabis plant.

When we take cannabinoids into our body exogenously(by ingestion), they can help support our endocannabinoid system if our body’s homeostasis is disrupted due to an imbalance of our own endocannabinoids, or when we have what is called clinical endocannabinoid deficiency

Though recently discovered, the endocannabinoid system regulates and controls many of our critical bodily functions. Researchers are investigating the ECS’s role in learning and memory and in...

23/07/2021

The entourage effect - synergistic cannabinoids and terpens interaction to control pain is a term popularized by Dr. Ethan Russo in his 2011 paper on cannabinoids. Further scientific evidence from University of Arizona researchers, please read on..

When it comes to the medicinal and therapeutic properties of Cannabis sativa, an unsolved mystery is whether there exists an “entourage effect,” whereby the pain-relieving effects of the plant as a whole are greater than any of its individual parts.

19/07/2021

Greenlab laboratory is functional at Lincoln for internal research. HPLC is capable of analyzing cannabinoids and GCMS for terpenes. Congratulations to the team on achieving this milestone.

30/04/2021

Greenlab proudly announce to take our research associate relationship to next level with Canadian Purplefarm Genetics .

Purplefarm Genetics Inc. (PFG), a privately held cannabis company, is pleased to announce a partnership agreement with Greenlab (Green Relief NZ Ltd trading as Greenlab), to develop next-generation medicinal cannabis strains under Health Canada and Ministry ...

17/04/2021

Greenlab is fast tracking its R&D. Difference between each flower is clearly distinct visually. Next step will be to harvest and look into the cannabinoid profiles in our state of the art laboratory setup next to the growing rooms.

17/02/2021

Greenlab signs medicinal cannabis supply deal with Australia’s largest distributor Cannvalate

https://smallcaps.com.au/greenlab-medicinal-cannabis-supply-deal-australias-largest-distributor-cannvalate/

04/02/2021

Despite critics of cannabis cultivation, Greenlab is confident unique strains will take market share.

Greenlab coverage on NBR - https://www.nbr.co.nz/story/greenlab-says-plant-first-focus-key-cannabis-success